[1] LutgensE , gijbelsM , SmookM , etal.Transforminggrowthfactor- (beta) mediatesbalancebetweeninflammationandfibrosisduringplaqueprogression.Arteriosclerosis, ThrombosisandVascularBiology[J].Dallas, 2002, 22 (6) ∶975-78.
|
[2]钱建民, 王学浩.肝癌患者转化生长因子β1及其受体的表达意义[J].中华实验外科杂志, 2000, 17 (6) ∶535-536.
|
[3]刘超, 区庆嘉.TGF -β1抑制肝癌细胞株BEL -7402的增殖[J].肝胆外科杂志, 1999, 7 (3) ∶219-221.
|
[4] RomieeuR , LacabanneV , KayibandaM , etal.Criticalstagesoftu morgrowthregulationtransgenicmiceharboringahepatocellularcar cinomarevealedbydistinctpatternsoftumornecrosisfactor-alphaandtransforminggrowthfactor-betamRNAproduction[J].InIm munol, 1997, 9∶1409-1412.
|
[5]刘超, 陈双, 区庆嘉.转化生长因子β1及其Ⅱ型受体在肝细胞癌中的基因表达[J].中华外科杂志, 1999, 37 (12) ∶740-742.
|
[6] BedossaP , PeltierE , TerrisB , etal.Transforminggrowthfactor-betal (TGF -β1) andTGF -β1receptorsinnormal, cirrhotic, andneoplastichumanlivers[J].Hepatology, 1995, 21∶760.
|
[7] KehrlJH , WakefieldLM , KobertsAB , etal.TransforminggrowthfacotrβisanimportantimmunomodulatoryproteinforhumanB -lymphocytes[J].JImmunol, 1986, 137∶3855.
|
[8] RobertsAB , SpornMB , AssoianPK , etal.Transforminggrowthfactortype-β:Rapidinductionoffibrosisandangiogenesisinvivoandstimulationcollagenformatoninvitro[J].ProNatlAcadSciUSA , 1986, 83∶4167.
|
[9] WangJ, HanW , ZborowskaJL , etal.Reducedexpressionoftrans forminggrowthfactorβtypeⅠreceptorcontributestothemalignancyofhumancoloncarcinomacells[J].JBiolChem, 1996, 271∶17366-17371.
|
[10] KimIY , AhnHJ, ZelherDJ, etal.Geneticchangintransforminggrowthfactorbeta (TGF -beta) receptortypeⅠgenecorrelateswithinsensitivitytoTGF -beta1inhumanprostatecancercells[J].CanRes, 1996, 56∶44.
|
[11] InagakiM , MoustakasA , LinHY , etal.Growthinhibitionbytransforminggrowthfactorbeta (TGF -beta) typeIisrestoredinTGF -beta-resistanthepatomacellsafterexpressionofTGF -betareceptortypeⅡcDNA[J].ProcNatlAcadSci, 1993, 90 (11) ∶5359-5363.
|
[12] KnausPI , LindemanD , DeCoteauJF , etal.AdominantinhibitorymutantofthetypeⅡtransforminggrowthfactorbetareceptorinthemalignantprogressionofacutaeousT -celllymphoma[J].MolCellBiol, 1996, 16 (7) ∶3480-3489.
|
[1] | Hao ZHANG, Linxun LIU, Zhanxue ZHAO, Hongshuai PAN, Xiaofan HOU, Zheng HUO. Role of transforming growth factor-β in the development and progression of pancreatic cancer[J]. Journal of Clinical Hepatology, 2022, 38(12): 2892-2896. doi: 10.3969/j.issn.1001-5256.2022.12.041 |
[2] | Wen QIN, Jianyu YANG, Taiwen CHEN, Haiping ZHENG, Xiaodong ZHU. Expression and significance of L1 cell adhesion molecule and transforming growth factor-β1 in pancreatic cancer tissue[J]. Journal of Clinical Hepatology, 2021, 37(6): 1404-1408. doi: 10.3969/j.issn.1001-5256.2021.06.035 |
[3] | YUSUFUKADIER·Maimaitinijiati, AIMAITI·Yasen, Li WenDing, Ran Bo, TUERGANAILI.aji, Shao YingMei, Wen Hao. Effect of the transforming growth factor-β1 signaling pathway in inducing the differentiation of hepatic progenitor cells[J]. Journal of Clinical Hepatology, 2020, 36(3): 620-623. doi: 10.3969/j.issn.1001-5256.2020.03.030 |
[5] | Zhao WeiHua, Wang YanHong, Cong Min. Regulatory effect of transforming growth factor-β on activation of hepatic stellate cells[J]. Journal of Clinical Hepatology, 2016, 32(11): 2195-2198. doi: 10.3969/j.issn.1001-5256.2016.11.044 |
[6] | An BaiQuan, Xin YongNing, Lu LinLin, Xuan ShiYing. Effect of PNPLA3 I148M mutation on expression of TGF- β1 in rat hepatic stellate cells[J]. Journal of Clinical Hepatology, 2016, 32(4): 769-771. doi: 10.3969/j.issn.1001-5256.2016.04.035 |
[7] | Feng Jie, Tang ZhengHao, Yu YongSheng. Expression of transcription factor Sp1 in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2013, 29(1): 65-67. |
[8] | Gao HuiXia, Liu YuZhen, Lu JianHua, Ye LiHong, Dai ErHei. Correlation of Foxp3 + Tregs and TGFβ1 expression with inflammation in livers of patients with primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(12): 952-955. |
[9] | Jiang Ying, A YiTuLa. Expression of TGFβ1、TIMP1 in liver cirrhosis and pathological significance[J]. Journal of Clinical Hepatology, 2009, 25(1): 39-41. |
[11] | Kang HaiYan, Dong JiangLong, Wang JianBin, Li BingShun, Zhang HongXia. Relationship between transforming growth factor β1 and liver fibrosis and liver function in 260 patients with hepatitis B [J]. Journal of Clinical Hepatology, 2009, 25(1): 61-62. |
[13] | Xu TingTing, Jiang MiaoNa, Jia YuJie, Che Ying. Ganfukang's effect on transforming growth factor β1 and laminin of experimental liver fibrosis rats[J]. Journal of Clinical Hepatology, 2005, 21(1): 30-31. |
[14] | Zhou Hui, Ma YingJi, Yang BaoShan, Zhu SiHe. Clinical evaluation of serum vascular endothelial growth factor and Insulin-like growth factor-Ⅱ assay in the diagnosis of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2004, 20(2): 106-107. |
[15] | Liu Fang, Li XiuPing, Zhang SuHuan, Li BingShun, Liu JinXing. Influence of serum TGF-β1 on cellular immune function in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2004, 20(6): 335-337. |
[16] | Bi Qing, Cheng Lei, Cui LiAn, Zhang JunFu. The effect of Kangxianruanjian on TGF β1 and it's the recepters in liver fibrosis in rats[J]. Journal of Clinical Hepatology, 2002, 18(3): 181-182. |
[17] | Li QingHua, Li Hui, Qin ChengYong, Han GuoQing. The significance of urine transforming growth factor-β1 (TGF-β1) and serum procollagen type Ⅲ (PCⅢ) , collagen type Ⅳ (Ⅳ-C) , hyaluronic (HA) and laminin (LN) in patient with chronic HBV related liver disease[J]. Journal of Clinical Hepatology, 2001, 17(3): 161-162. |
[18] | Zhang Min, Zhang LingXia, Xin ShaoJie, Zhao JingMin, Wang SongShan, Wang LinJie. The relationship between transforming growth factor β1 and liver fibrosis[J]. Journal of Clinical Hepatology, 2000, 16(1): 32-33. |